Sharekhan

Zim Laboratories Ltd

Mon 16/02/2026,12:59:12 NSE: ZIMLAB

₹ 70.42 -0.81 (-1.14%)
BUY NOW Buy Zim Laboratories Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Zim Laboratories Ltd

Mon 16/02/2026,13:13:0

Zim Laboratories Ltd

Mon 16/02/2026,12:59:12 | NSE : ZIMLAB

₹ 70.42-0.81 (-1.14%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 71.58

Previous Close

₹ 71.23

Volume

71632

Mkt Cap ( Rs. Cr)

₹343.20

High

₹ 71.63

Low

₹ 68.80

52 Week High

₹ 127.00

52 Week Low

₹ 65.52

Book Value Per Share

₹ 51.57

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Zim Laboratories Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

4 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

88%

Sell Order Quantity

12%

Bid Price

Qty

70.46

601

70.00

7

70.00

252

70.00

310

70.00

3

Bid Total

148881

Bid Price

Qty

70.50

399

71.00

140

71.00

86

71.00

100

71.00

55

Bid Total

21196

Option Chain

Analyzes market sentiment, predicts Zim Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    13 Feb 2026, 5:38PM Audio recording of Q3 & 9M FY26 Earnings Conference Call

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2026, 5:33PM Zim Laboratories Limited has informed the Exchange about Link of Recording

  • Zim Laboratories - Copy of Newspaper Publication

    12 Feb 2026, 4:40PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - Outcome of Board Meeting

    11 Feb 2026, 8:01PM Zim Laboratories Limited has informed the Exchange regarding Board meeting held on February 11, 2026.

  • Zim Laboratories - Action(s) initiated or orders passed

    11 Feb 2026, 7:52PM Zim Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed

  • Zim Laboratories - Disclosure Under Regulation- 30

    11 Feb 2026, 7:49PM Please find enclosed the disclosure w.r.t to GST demand Order received from office of Deputy Commissioner of State Tax, Nagpur (MH)

  • Zim Laboratories - Investor Presentation

    11 Feb 2026, 7:46PM Zim Laboratories Limited has informed the Exchange about Investor Presentation

  • Zim Laboratories - Disclosure Under Regulation- 30

    11 Feb 2026, 7:44PM Please find enclosed the Earnings presentation for Q3 & 9M FY26

  • Zim Laboratories - Disclosure Under Regulation 30- Incorporation Of Wholly Owned Subsidiary

    11 Feb 2026, 7:27PM Please find enclosed disclosure w.r.t to incorporation of wholly owned subsidiary of the company in Chile, LATAM region.

  • Zim Laboratories - Incorporation

    11 Feb 2026, 7:12PM Zim Laboratories Limited has informed the Exchange about Incorporation

  • Zim Laboratories Q3 net profit down 2.07% at Rs 4.26 cr

    11 Feb 2026, 7:10PM The company reported standalone net profit of Rs 4.26 crore for the quarter ended December 31, 2025 as compared to Rs 4.35 crore in the same period la

  • Zim Laboratories - Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended 31St Decem

    11 Feb 2026, 7:10PM Enclosed Unaudited Financial Results (Consolidated and standalone) for the quarter and nine months ended 31st December, 2025 along with limited review

  • Zim Laboratories - Outcome of Board Meeting

    11 Feb 2026, 7:10PM Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

  • Zim Laboratories - Outcome of Board Meeting

    11 Feb 2026, 7:06PM Outcome of the Board Meeting

  • Zim Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held To Consider And Approve Unaudited Financial Result

    11 Feb 2026, 6:52PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of D

  • Zim Laboratories - Copy of Newspaper Publication

    7 Feb 2026, 6:06PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Feb 2026, 4:10PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    6 Feb 2026, 4:01PM Intimation of Earnings Conference Call scheduled to be held on 13 February, 2026

  • Zim Laboratories - Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone & Consolidated Financial R

    5 Feb 2026, 7:18PM Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Change in Management

    2 Feb 2026, 9:07PM Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Appointment of Senior Management Personnel

  • Zim Laboratories - Change in Management

    2 Feb 2026, 9:05PM Zim Laboratories Limited has informed the Exchange about change in Management

  • Zim Laboratories - Notice Of Extra-Ordinary General Meeting Of The Company

    23 Jan 2026, 5:51PM Notice of Extra- Ordinary General Meetings of the Company schedule to be held on 16th February, 2026

  • Zim Laboratories - Shareholders meeting

    23 Jan 2026, 5:50PM Zim Laboratories Limited has informed the Exchange regarding Notice of Extraordinary General Meeting to be held on February 16, 2026

  • Zim Laboratories - Copy of Newspaper Publication

    22 Jan 2026, 3:35PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

  • Zim Laboratories - Preferential issue

    21 Jan 2026, 11:14AM Zim Laboratories Limited has informed the Exchange about Preferential issue

  • Zim Laboratories - Outcome of Board Meeting

    21 Jan 2026, 11:14AM Zim Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on January 21, 2026.

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Preferential Issue

    21 Jan 2026, 11:20AM Please find enclosed the disclosure regarding the Preferential Issue

  • Zim Laboratories - Board Meeting Outcome for Outcome Of Board Meeting Held On 21.01.2026

    21 Jan 2026, 11:18AM Please find enclosed the outcome of Board Meeting held on 21.01.2026

  • Zim Laboratories - Updates

    20 Jan 2026, 1:17PM Zim Laboratories Limited has informed the Exchange regarding 'Amendment to the Code of Practices and Procedures for Fair Disclosure of Unpublished P

  • Zim Laboratories - Amended Code Of Practices And Procedures For Fair Disclosure Of Unpublished Prize Sensitive Information

    20 Jan 2026, 1:24PM Amended Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information

  • Zim Laboratories - Board Meeting Intimation for Considering The Proposal For Raising Funds

    15 Jan 2026, 8:42PM Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 ,inter alia, to consider and

  • Zim Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    13 Jan 2026, 3:01PM As of December 2025, 33.26% is owned by Indian Promoters and 66.74% by Public. <p align=justify> Top five Promoters holding highest number of shares o

  • Zim Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 12:03PM Certificate under Regulation 74 (5) of SEBI (DP) Regulations, 2018 is enclosed herewith.

  • Zim Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2026, 12:03PM Zim Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Zim Laboratories - Trading Window

    29 Dec 2025, 12:38PM Zim Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Dec 2025, 11:52AM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Dec 2025, 11:54AM Intimation of Schedule of Investor meeting to be held on Friday, 19th December, 2025 at 12:30 P.M (IST)

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Dec 2025, 7:00PM Intimation of Schedule of Investor meeting to be held on Thursday 11th December, 2025 at 11:30 A.M (IST)

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Dec 2025, 6:58PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

    3 Dec 2025, 1:49PM Zim Laboratories Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    3 Dec 2025, 1:50PM Press release for grant of permission to manufacture and market FDC of Naproxen Delayed Release and Esomeprazole received from CDSCO - Directorate Gen

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    17 Nov 2025, 7:04PM Please find enclosed transcript of earnings call held on 14th November, 2025

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Nov 2025, 7:01PM Zim Laboratories Limited has informed the Exchange about Transcript
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Zim Laboratories Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 356.6793 338.3068 253.7463 221.2899 223.4768
Liabilities 356.6793 338.3068 253.7463 221.2899 223.4768
Equity 48.7258 48.7258 48.7258 16.2419 16.2419
Gross Profit 43.2684 40.1024 51.1911 37.934 36.8113
Net Profit 11.744 16.7555 25.0088 13.0128 5.6162
Cash From Operating Activities 50.602 11.472 35.2318 47.0265 31.8967
NPM(%) 3.12 4.58 6.3 3.94 1.84
Revenue 375.6355 365.4732 396.5313 329.4937 303.6294
Expenses 332.3671 325.3708 345.3402 291.5597 266.8181
ROE(%) 4.67 6.66 9.95 5.17 2.23

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Zim Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 737.95 -1.63 43.82 40.97 301.39 0.68
Lotus Eye Hospital and Institute Ltd 118.73 5.00 383.00 149.30 3.55 0.00
Vaishali Pharma Ltd 8.02 0.88 0.00 936.59 3.13 0.00
Astec Lifesciences Ltd 620.80 -2.53 0.00 140.79 -604.77 0.00

Company Info

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023. 2025-ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announced Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region.

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023. 2025-ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announced Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region.

Read More

Parent Organisation

Zim Laboratories Ltd.

Founded

14/02/1984

Managing Director

Dr.Anwar Daud

NSE Symbol

ZIMLABEQ

FAQ

The current price of Zim Laboratories Ltd is ₹ 70.42.

The 52-week high for Zim Laboratories Ltd is ₹ 71.63 and the 52-week low is ₹ 68.80.

The market capitalization of Zim Laboratories Ltd is currently ₹ 343.20. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Zim Laboratories Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Zim Laboratories Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zim Laboratories Ltd shares.

The CEO of Zim Laboratories Ltd is Dr.Anwar Daud, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT